The new federal trade secrets law has major ramifications for intellectual property and employment disputes.
Post Type of: Article
The school claimed Gilead Sciences used a drug it developed to create and heavily profit off of Hepatitis C medications.
Medical properties are seen as solid investments.
New report adds to evidence that employees are paying more for their own care.
Diagnostic kit-maker DiaSorin tapped by U.S. to roll out test, process results.
Evelo Biosciences joins four others as investment, research dollars flow into field.
Some tips for managing those annual forays into strategy and vision.
The best opportunities for networking this month.
Finding your personal 212 degrees may be easier than you think.
Both individuals are more than 20-year veterans of General Mills.
The women’s retailer has yet to find a winning formula to improve its woes.
Jeff Jones will be in charge of marketing, operations and customer support for the ridesharing behemoth.
The deal could see the fluid management company expanding its product sales to government organizations, including contracts with budgets totaling $33 billion.
All but one of the state’s industries experienced gains in employment or level employment compared to the previous month.
Prime’s CEO said the partnership could allow it to slow down “this run-away freight train of rising drug costs.”
This company also recently completed its acquisition of HeartWare.
The additional plant will also allow the company to boost its staff size by more than 40 percent.
The med-tech company expected to complete the deal in late October.